European Union EU
GROUP: REGIONAL BODIES
- Topic A: Sustainable Agriculture
- Topic B: AI Regulation in Global Medicine
TOPIC A Sustainable Agriculture
TOPIC B AI Regulation in Global Medicine
DELEGATION SIZE Double
EXECUTIVES
- Emily Kim (she/her)
- Esther Ma (she/her)
The European Union (EU) is a political and economic union and principal decision-making body of the EU in which member state ministers meet to adopt legislation, coordinate policy, and force common positions on the challenges facing Europe and the wider world. The goal of the EU is to act as a strong, unified entity to promote shared values and collective prosperity. Delegates will speak and negotiate as representatives of their assigned EU member states, balancing national interests against the collective ambitions of the bloc. This year, the committee confronts two complex issues that demand supranational coordination. With either topic, delegates will have to think creatively and critically about how the EU can work as a whole to achieve its goals.
TOPIC A: Sustainable Agriculture
Agriculture feeds the world, but at increasingly higher costs. Environmentally harmful agricultural practices persist across regions, contributing to soil degradation, biodiversity loss, and climate change. This topic focuses on how the European Union and its institutions can strengthen the adoption of sustainable agriculture within member states and partner regions. Delegates may consider policies that promote agroecological practices, support farmers through targeted subsidies, and incentivize climate-resilient farming techniques. Discussions will also address financing mechanisms, collaboration with local farming communities, and the integration of sustainability goals into broader agricultural and environmental policy frameworks. Ultimately, this topic challenges delegates to develop practical, inclusive strategies that balance productivity with environmental stewardship, while reflecting on the role of collective European action in advancing long-term agricultural sustainability.
TOPIC B: AI Regulation in Global Medicine
AI has become increasingly prevalent in all organizational spheres across the world. In particular, AI has unlocked extraordinary possibilities in medicine, from personalizing patient care to AI cancer detecting. The international community has struggled to reckon with these new technologies, as they pose many governance challenges. There are concerns of diagnostic algorithms trained on non-representative datasets, consumer privacy, and overall the ethics of AI in such a human-facing industry. This committee asks delegates to consider how technological development can intersect with global health equity. Should the EU coordinate with member states to establish minimum ethical standards for AI assisted tools? Would solutions look the same to countries across income levels? Delegates will think critically about how cooperation in medicine should look like, in the face of rapid technological advancement.
